Targeting cytokines in asthma therapy: round one
- 1 December 2000
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 356 (9248) , 2114-2116
- https://doi.org/10.1016/s0140-6736(00)03486-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Interleukin-9 Upregulates Mucus Expression in the AirwaysAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitisJournal of Allergy and Clinical Immunology, 2000
- Effects of Chronic Anti-Interleukin-5 Monoclonal Antibody Treatment in a Murine Model of Pulmonary InflammationAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Allergen-specific Th1 cells fail to counterbalance Th2 cell–induced airway hyperreactivity but cause severe airway inflammationJournal of Clinical Investigation, 1999
- Interleukin-13: Central Mediator of Allergic AsthmaScience, 1998
- Requirement for IL-13 Independently of IL-4 in Experimental AsthmaScience, 1998
- Dissociation between Airway Inflammation and Airway Hyperresponsiveness in Allergic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.The Journal of Experimental Medicine, 1996
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989